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Abstract Peptide synthetases and acyl-CoA-synthetases form 
acyl adenylates which are transferred to CoA or enzyme-bound 
pantetheine. To verify the existence of an adenylate domain in 
peptide synthetases, a 60.8 kDa fragment of tyrocidine 1-synthe- 
tase was constructed by a 1629 bp deletion, expressed in Esche- 
richia coli, and characterized. The truncated multienzyme acti- 
vated phenylalanine and substrate analogues with comparable 
kinetics as the over-expressed synthetase, as judged by ATP- 
[32p]pp~ exchange reaction. Thus the N-terminal domain resem- 
bling an acyl-CoA-synthetase is an autonomous tructural ele- 
ment. This N-terminal domain is followed by a cofactor binding 
domain, resembling acyl carrier proteins involved in polyketide 
formation. 
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structed of modules, each contributing one amino- or hydroxy 
acid to the peptide structure. Each module contains an adenyl- 
ate-forming domain, a cofactor binding site, and a condensa- 
tion/modification domain. The adenylate forming domains dis- 
play significant similarity to acyl-CoA-synthetases and related 
proteins. We have predicted, by alignment of sequences of these 
three classes and those of acyl carrier proteins also binding 
4'-phosphopantetheine, th  boundaries of adenylate and cofac- 
tor domains. The linker region is not rich in Ala, Pro and Glu 
residues, as in fatty acid synthases and 2-oxo-acid dehydro- 
genases containing similar cofactor domains. Still, amino acids 
frequently found in linker regions are dominating. Upon dele- 
tion of the cofactor and following functional domains of tyro- 
cidine synthetase 1,a stable N-terminal fragment was obtained 
which catalysed adenylate formation with similar kinetic prop- 
erties as the apo-form of the peptide synthetase [8]. 
1. Introduction 
A superfamily of carboxyl-group activating enzymes con- 
tains peptide synthetases, acyl-CoA-synthetases, insect lucif- 
erases, and certain amino acid-adding enzymes [1-3]. Common 
to these adenylate-forming enzymes are a group of motifs iden- 
tified by Bairoch, who described these as AMP-binding motifs 
[4]. In the meantime, sequences of at least 25 peptide syn- 
thetases, comprising altogether 58 respective domains, and 38 
other proteins have been obtained [1,3] and additional motifs 
described (A-I; Fig. 1) [1,5-8]. This superfamily of enzymes and 
multienzymes has been subdivided according to structural sim- 
ilarities into four classes [2]. Class 1 is dominated by eukaryotic 
acyl-CoA-synthetases, class 2 consists mainly of peptide syn- 
thetases, class 3 are acetyl-CoA-synthetases, and class 4 lucif- 
erases and other acyl-CoA-synthetases of prokaryotic and 
plant origin. Only the second class of these AMP-binding pro- 
teins (SWlSS-PROT) extends in size considerably, and, con- 
trary to the rest, does not transfer the respective activated 
acyl-compounds to CoA [1]. Instead, an intra-enzymatic rans- 
fer to a covalently attached 4'-phospho-pantetheine group oc- 
curs [10]. To these thioester intermediates likewise activated 
intermediates are transferred, either as CoA derivatives or as 
enzyme-attached sters, and undergo a directed condensation 
reaction [10,I 1]. 
For these additional catalytic properties a cofactor-attach- 
ment motif has been identified (J), and other motifs (K-Q) have 
been suggested to function in condensation or substrate modi- 
fication reactions [8] (Fig. I). Peptide synthetases are con- 
*Corresponding author. Fax: (49) (30) 3142 4783. 
E-mail: hans@cicsg.tk.tu-berlin.de 
2. Materials and methods 
2.1. Materials" 
DNA restriction endonucleases were purchased from Gibco BRL 
and Appligene. T4 DNA ligase and Klenow fragment were products 
of Boehringer-Mannheim. [32P]PP i was from DuPont, ~4C-labeled 
L-phenylalanine from Amersham/Buchler, ATP and dithioerythritol 
(DTE) were purchased from Sigma. 
2.2. Bacterial strains and growth conditions 
The Escherichia coli strain used for plasmid propagation and enzyme 
expression was XLl-blue [12]. Transformants of this strain carrying 
recombinant plasmids were cultured in Luria-Bertani medium supple- 
mented with 50/lg/ml ampicillin. 
2.3. Isolation of plasmid DNA 
The plasmid pGC12 contains a 3.5 kb HinclI fragment (containing 
the TYI coding region) from pBT2 [13] and carries the ampicillin 
resistence gene and a portion of the lac operon, including the lac 
promoter, operator and part of the Z gene. Plasmid DNA was isolated 
by the alkali method of Birnboim and Doly [14]. 
2.4. DNA manipulations 
Digestions, ligation, filling in of nucleotides, and other DNA manip- 
ulations were performed as described by Sambrook et al. [15]. 
2.5. Transformation and selection 
Competent E. eoli XLl-blue cells were transformed using the proce- 
dure of Mandel and Higa [16] or Dagert and Ehrlich [17]. Transfor- 
mants were selected on plates containing 50/.tg/ml ampicillin. 
2.6. Enzyme purification 
All operations were carried out at 0~°C, except he final purification 
step on TMAE which was performed at room temperature. The har- 
vested cells were resuspended in a threefold volume of 100 mM Tris- 
HC1 (pH 7.5), containing 10 mM dithioerythritol (DTE), 1 mM EDTA, 
150 mM NaCI, 10% (v/v) glycerol, 2 mM MgSO4, 2/~g/ml DNase and 
300 ~g/ml ysozyme. After being stirred for 1 h, the suspension was 
sonified. The cell debris was sedimented bycentrifugation at 16,000 rpm 
for 25 min and discarded. Polyethylenimin (PEI) was added to the 
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supernatant to give a final concentration of 0.1%; the mixture was 
stirred for 30 min and centrifuged at 18,000 rpm for 10 min. (NH4)2SO 4 
was added as a saturated solution to give a final concentration f60%, 
and the mixture was stirred for 1 h. The precipitate was dissolved in a 
minimal volume of buffer A (50 mM Tris, pH 7.5, 1 mM DTE, 0.1 mM 
EDTA, 10% glycerol) containing 150 mM NaC1, and was eluted from 
a Sephacryl S-300 HR column (Pharmacia) with buffer A. Fractions, 
which showed activity in the ATI? [~2P]PP~ exchange assay, were 
pooled, dialysed against buffer A and applied to an anion-exchange 
DEAE-Sepharose CL-6B column (Pharmacia). The column was eluted 
with a linear gradient of 0400 mM NaC1 in buffer A. Active fractions 
were pooled, adjusted to 1 M NaCI in buffer B (50 mM Tris, pH 7.5, 
1 mM DTE, 0.1 mM EDTA), and applied to a phenyl-Sepharose CL-4B 
column (Pharmacia). Elution was performed with a linear gradient 
from 1 M to 0 M NaC1 in buffer B. After dialysis against buffer B, the 
enzyme was applied to Fractogel TSK TMAE-650 in a Superformance 
150-10 column (Merck). Elution was carried out using a linear gradient 
from 0 to 500 mM NaC1 in buffer B. 
2.7. SDS-PAGE and determination f N-terminal sequence 
SDS-PAGE was performed in 10% polyacrylamide g ls according to 
the method of Laemmli [18]. After electrophoresis, gels were stained 
with Coomassie brilliant blue R-250. Alternatively proteins were trans- 
ferred to Immobilon polyvinylidene difluoride membranes. N-Terminal 
sequencing was done with an Applied Biosystems protein sequencer 
(model 473A). 
2.8. Western blot 
Western blot analysis was performed according to Towbin et al. [19]. 
2.9. Enzyme assays 
ATP-[32P]PP i exchange was measured essentially as described by 
Pavela-Vrancic [20]. The reaction mixture contained, in a final volume 
of 70 ,ul, 50 mM Tris-HC1, pH 7.4, 0.14 mM ATE 0.7 mM Mg 2÷, 
0.07 mM EDTA, 1 mM DTE, 0.07 mM PPi, 0.1 ~tCi [32P]PP i and 
1.4 mM phenylalanine. The reaction was started by addition of enzyme 
and allowed to proceed for 15 min at 37°C. For kinetic measurements 
ATP-[3ap]pP. exchange was performed at varying substrate concentra- 
tions, 0.01 0.1 mM D-Phe and 0.014).4 mM ATE 
2.10. Determination f protein content 
The protein concentration was measured by the Bradford method 
[21] with bovine serum albumin as standard. 
2.11. Isoelectric focusing 
The pI of the enzyme was determined on Servalyt Precotes (pH range 
3-10) and Servalyt PreNets (pH range 4~6) from Serva (Heidelberg, 
Germany). The purified enzyme preparations were previously desalted 
by dialysis. 
2.12. Mass spectrometric analysis 
Mass spectrometric analysis was performed with a Bruker Reflex 
laser desorption mass spectrometer using sinapinic acid as a matrix 
(Bruker-Franzen Analytic GmbH, Bremen, Germany). 
3. Results 
3.1. Construction of deletion and expression 
Within the C-terminal region of the tycA gene (3261 bp) a 
1629 bp-deletion was constructed making use of ClaI and 
EcoRV restriction sites (Fig. 2). In the resulting truncated mul- 
tienzyme, 543 amino acids between residues Ser TM and Ile ~°vv 
have been deleted, combining the N-terminal 533 amino acids 
with the C-terminal decapeptide, with a reduction in the calcu- 
lated molecular mass from 122,590 to 60,762 Da. Expression 
was conducted in E. coli XLl-blue without induction, presum- 
ably using the tycA promoter. The corresponding gene product 
was identified using TYl-specific antibodies. After disintegra- 
tion of cells, 80% of the over-expressed 61 kDa protein re- 
mained in the insoluble fraction. The soluble protein was puri- 
fled by 60% ammonium sulfate precipitation, gel-filtration on 
Sephacryl S-300, anion-exchange chromatography on DEAE-  
CL-6B, hydrophobic interaction chromatography on Phen- 
ylsepharose CL-4B, and anion-exchange chromatography on 
Fractogel TMAE-650. The homogeneity of the protein was 
demonstrated by SDS-PAGE (Fig. 3) and isoelectric focusing 
(pI 5.1) (data not shown). 
3.2. N-Terminal sequencing and mass ,~pectrometric analysis 
The N-terminal sequence (MLANQANLIDN)  of the dele- 
tion mutant was shown to be identical to TY 1. A sample of the 
purified TY1 fragment expressed in E. coli was analyzed by 
laser desorption mass spectrometry. The mass was determined 
to be 60,975 Da, which is within the experimental error of the 
calculated value of 60,762 Da (data not shown). 
3.3. Enzymatic haracterization of the TY1 fragment 
The enzyme fragment was shown to retain adenylating activ- 
ity by ATP-[32p]pP i exchange, although the ability to thioester- 
ify phenylalanine was totally lost. The kinetics of phenylalanine 
activation by the fragment was studied by ATP-[32P]PP~ ex- 
change. The turnover number (kc, t 0.4 s -~) obtained by ATP 
[3:p]pp~ exchange activity measurements is in good agreement 
with the value obtained for TY1 expressed in E. coli (koat 0.57 
s -t) [8]. Both enzymes show similar kinetic patterns, and the 
dissociation constant for c-phenylalanine, which was deter- 
mined from Lineweaver-Burk plots to be K d -- 0.1 + 0.02 mM, 
corresponds to the values obtained for the wild-type enzyme 
and the expressed protein (K~ = 0.04) [8]. 
3.4. Substitution of phenylalanine by other amino acids' and 
substrate analogues in ATP-[S2p]pPi exchange 
Substrate specificity with regard to amino acid activation was 
examined by measuring the ATP-[32p]pP~ exchange in the pres- 
ence of a series of amino acids and phenylalanine analogues 
(Table 1). The highest activity was obtained with the natural 
substrate L-phenylalanine. The enzyme strongly prefers amino 
acids carrying aromatic side chains, tryptophan and kynuren- 
ine were not accepted. Glycine, alanine, serine, threonine, 
isoleucine, cysteine, glutamine, asparagine, and proline were 
not recognized, while valine, leucine, aspartate, glutamate, and 
lysine showed a slight reaction (< 1%). Surprisingly activation 
A B C D EF,G H,I 
A B C D EF,G H,I J K L M N O 
B1 
A B C D EF,G H,I J K L M N OP,Q 
B2 
Fig. 1. Organization of adenylate-forming enzymes involved in car- 
boxyl group activations. (A) Acyl-CoA synthetases; (B1) peptide syn- 
thetases; (B2) peptide synthetases with epimerizing function. The boxed 
motifs of peptide synthetases represent the following core sequences 
[1,8]: A, LTXXELXXXAXXLXR; B, AVXXAXAXYVXIDXXYPX- 
ER; C, YTSGTTGXPKG; D, IIXXYGXT; E, GELXIXGXXVAR; 
F, RLYRTGDL; G, IEYLGRXDXXQVKIRXXRIELGEIE; H, LX- 
XYMVP; I, LTXXGKLXRKAL; J, LGGXSIXA1; K, (B2) XXLXP- 
IQXWFXXX, (B1) YPSVXXQXRMYIL; L, (BI) LIXRHEXL, (B2) 
LXXXHDXX; M, (B1) DMHHIIXDGXSXXIX, (B2) XXHHXXV- 
DXVSWXIL: N, (B1) LSKXGQXDIIXGTPXAGR, (B2) VXXEGH- 
GRE; O, (B1) IXGMFVNTXLALR, qB2) TVGWFTXXXPXXL; 
P, PXXGXGY; Q, VXFNYLG. 
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EcoRV ,HincII 
HincII. 
1. Clal/EcoRV 
2. fill in I 3. ligation 
ClaI "i 
Hinci1 ~ - ~ ~  ~ 
'HincII 
Fig. 2. Construction of pD1, containing 1632 bp of the tycA gene (3261 bp). 
of methionine was observed, which so far has not been detected 
in enzymatically formed peptide structures. From these results 
it can be concluded that amino acid substrate specificity of the 
synthetase fragment is essentially unchanged when compared 
to the wild-type enzyme [8]. 
4. Discussion 
Acyl-CoA-synthetases and peptide synthetases share a num- 
ber of common motifs, termed A-I  as described and defined in 
Fig. 1. In peptide synthetases these motifs are found in the 
N-terminal parts of the multienzyme or their respective mod- 
ules, and are followed by a pantetheine attachment motif J 
[5,8,22,23]. Sequence alignments as shown in Fig. 4 indicate 
that the region comprising motifs A-I is an N-terminal domain 
catalyzing the formation of acyl adenylates, which is followed 
by a cofactor binding domain concluded by certain similarities 
to acyl carrier proteins likewise binding 4'-phosphopantetheine. 
Surprisingly the proposed linker region between these domains 
1 2 3 4 
190 kDa ,,,- 
125 kDa ,-- 
88 kDa 
65 kDa 
56 kDa 
38 kDa 
34 kDa 
Fig. 3. SDS-PAGE analysis of the truncated tyrocidine synthetase 1 
summarizing purification: lane 1, crude extract; lane 2, after purifica- 
tion by gel-filtration on Sephacryl S-300; lane 3, after anion-exchange 
chromatography onDEAE-Sepharose; lane 4, after chromatography 
on phenyl-Sepharose; lane 5, after anion-exchange chromatography on 
Fractogel TMAE-650 (10% SDS-PAGE). 
did not show the Ala/Pro/Glu-enriched sequences detected in 
fatty acid synthases [24], polyketide synthases [25] or 2-oxo- 
dehydrogenase cofactor binding domains [26]. In an analysis of 
domain linker regions, a preference of certain amino acids has 
been confirmed [27], including Thr, Ser, Pro, Asp, Gly, while 
others are rare (Trp, Cys, His, Phe, Met). Such a preference is
indeed observed here, together with a very low conservation of 
residues. This apparently higher mutation rate ('hot spot') is 
considered an indication of a domain boundary [28]. 
Additional information on possible structural domains or 
structural modules was thought o be derived from exon struc- 
tures [29]. The class of peptide synthetases, however, do not 
contain introns, despite their considerable gene sizes of up to 
45.6 kb in eukaryotic organisms [30]. From exon data of the 
acyl-CoA-synthetase and luciferase structures [31 33], no clues 
could be obtained on possible substructures within the adenyl- 
ate domain. A recent analysis of the exon theory concluded that 
no correspondence exists between protein structure and exons 
[341. 
More reliable evidence can be obtained from limited proteol- 
ysis data, as this method is generally used to prepare stable 
domains. Tryptic digestion of gramicidin S synthetase 2, a 
Table l 
ATP [32p]pp~ exchange activity of the truncated tyrocidine synthetase 
1 in the presence of various amino acids and phenylalanine analogues 
Amino acid Activity (%) 
L-Phenylalanine 100 
3-(2'-Thienyl)- L-alanine 95 
D-Phenylalanine 86 
p-Fluoro-phenyl-L-alanine 77 
L-Phenylserine 47 
p-Chlorophenyl-L-alanine 45 
L-Tyrosine 16 
3-(l'-Naphtyl)-L-alanine 9 
3,4,-Dimethoxy-phenyl-L-alanine 5 
o-Benzyl-L-serine 3 
4-Hydroxy-3-methoxy-phenyl-L-alanine 1 
L-Kynurenine 0 
L-Methionine 5 
Activity was calculated relative to the values obtained with L-phenyl- 
alanine. 
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ACPECOLI S ~ ER-'_'~KI~I G E ~ Q E ~ A  - ~ E ~ D T ~ Z ~ E E  E FDTE ~EE~KI  ~Q~I  D~NGHQ 
ACPRHIME SD~KI~ I D~AE ~S EGA - ~ I DD~D~: / :~E EE FGVE ~D~S I L~I~VK~E KAQA 
ACPeryt MDRKE~F ER~E~pAEQ~ TE EA - DLRE I )~DL~S~ED EVGMR~QS~EG IE~G~ELTLDLVARLATASAAD K PEAAS 
DEBS2 (N) . . QQEN~/LEI~qANAVAE~rJ~ESAAE INVRR- ~$EL~N~R~SASTGLR~PASL~D~QH/~RARL.  - 
Fig. 4. Alignment of peptide synthetase quences (TY 1, GSX), with acyl-CoA synthetases, luciferase and carboxylic acid- and amino acid-activating 
enzyme, respectively, and acyl carrier proteins type 1 and type 2. The cleavage site ($) is located between the I and J Box. LUCILUCCR, luciferin 
4-monooxygenase from Luciola cruciata; ENTE, enterobactin synthetase component E (dihydroxybenzoic a id-activating enzyme) from E. coli; 
LCFAECOLI, long-chain fatty acid-CoA ligase from E. coli; 4CL1PETCR, 4-coumarate-CoA ligase 1 from Petroselinum crispum (parsley); 
ACUAALCEU, acetyl-CoA synthetase from Alcaligenes eutrophus; Dae, D-alanine-activating enzyme from Lactobacillus casei; TY1, tyrocidine 
synthetase 1 from Bacillus brews; GS 1, gramicidine synthetase 1 from Bacillus brevis; GS2, gramicidine synthetase 2 from Bacillus brevis; ACPECOLI, 
acyl carrier protein (ACP) from E. coli; ACPRHIME, ACP from Rhizobium meliloti; ACPERYT, ACP from Saccharopolyspora erythraea; DEBS2 
(N), ACP region of 6-deoxyerythronolide-B synthase 2 from Saccharopolyspora erythraea. 
512 kDa multienzyme integrating 4 modules, led to amino acid- 
activating domains of I 10-115 kDa [35-37]. The Pro-activating 
domain has been analysed in detail, subcloned, and can be 
concluded to be truncated before the J-motif [38]. The 6-(L-~- 
aminoadipyl)-L-cysteinyl-D-valine sy thetase, containing three 
modules, has been digested by subtilisin, and some fragments 
have been identified by N-terminal sequencing [5]. Cleavage 
sites are found between the I and J, and the J and K motifs. 
To construct a truncated peptide synthetase module, the 
tycA gene was used, containing a ClaI site permitting cleavage 
between the I and J box, and an EcoRV site leaving the 
C-terminal decapeptide. TY1 or tyrocidine synthetase 1 is in- 
volved in the initiation of biosynthesis of the cyclodecapeptide 
tyrocidine. It activates phenylalanine as aminoacyl adenylate, 
which is used to aminoacylate an enzyme thiol group, presum- 
ably 4'-phosphopantetheine. This thioester intermediate is epi- 
merized before its transfer to a prolyl-thioester bound to tyro- 
cidine synthetase 2. Removal of the J box is thus expected to 
abolish both thioester formation and epimerization, which has 
been confirmed (results not shown). Ser-to-Ala point mutations 
in TY1 and surfactin synthetases within the J box motif have 
also demonstrated loss of aminoacylation ability [39,40]. 
Attempts to over-express peptide synthetases or modules for 
detailed characterization have been carried out with gramicidin 
S synthetase 1 [38], tyrocidine synthetase 1 [8], the serine-acti- 
vating enzyme of the enterobactin pathway [41], and the ami- 
noadipate activating module of ACV synthetase [42]. In none 
of the cases have enzyme activities comparable to the wild-type 
enzymes been reported concerning aminoacylation, which has 
been attributed to incomplete post-translational processing. At 
least in the first two cases, aminoacyl adenylate formation 
seemed to be conserved; however, a more detailed analysis of 
the over-expressed tyrocidine synthetase 1 revealed a signifi- 
cantly decreased rate in ATP-[32p]pP i exchange [8]. This de- 
creased rate, which is attributed to the apo-enzyme, has been 
confirmed for the fragment described here. Thus the adenylate 
domain retained an essentially unchanged structure compared 
to the apo-enzyme, which again showed unchanged binding 
constants when compared to the wild-type isolate, probably 
representing the holo form. 
This result suggests that, in enzymatic peptide biosynthesis, 
amino acid activation proceeds in complete analogy to acyl 
activation, preceding transfer to coenzyme A. Presumably for 
reasons of stability, free aminoacyl CoA esters are not observed 
in the cellular context. Aminoacyl adenylates either react di- 
rectly with respective acceptors (amino acid-adding enzymes) 
or aminoacylate enzyme-attached 4'-phosphopantetheine. To 
what extent acyl-CoA-synthetase-corresponding fragments of 
peptide synthetases have maintained binding and transfer prop- 
erties of and to CoA remains to be studied. Fragments of this 
size may have unchanged substrate binding properties in gen- 
eral, and may thus be suited for module identification and 
studies of specificity alterations. Over-expression studies have 
been unsuccessful in several cases employing complete modules 
or larger multienzyme fragments ([42,43], H. van Liempt, per- 
sonal communication). 
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